Although baseline LAG-3 and PD-1 levels in tumour samples did not correlate with response, we observed increased frequencies of memory CD4+ and effector CD8+ T cells in the posttreatment tumour specimens of patients with favourable treatment response. The gene discussed is LAG3; the disease is neoplasm.